Trigyn Technologies Limited has fulfilled its regulatory obligation by publishing its unaudited financial results for the quarter ended December 31, 2025, in newspapers as required under Regulation 47 of the SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015. The company published the results in Business Standard and Mumbai Mitra on February 12, 2026, following board approval on February 10, 2026.

Regulatory Compliance and Publication

The company submitted the newspaper publication copies to both BSE Limited (Scrip Code: 517562) and National Stock Exchange of India Limited (Company Code: TRIGYN) on February 12, 2026. Company Secretary & Compliance Officer Anmol Chaturvedi digitally signed the submission documents, ensuring compliance with stock exchange requirements.

Consolidated Financial Performance

Quarterly Results (Q3FY26)

The published results show consolidated revenue of Rs. 25,803.19 Lakhs for Q3FY26 compared to Rs. 20,669.68 Lakhs in Q3FY25. Net profit after tax reached Rs. 69.12 Lakhs for the quarter, with total comprehensive income of Rs. 964.39 Lakhs including other comprehensive income.

Nine-Month Performance (9M FY26)

For the nine months ended December 31, 2025, consolidated revenue increased to Rs. 72,448.30 Lakhs from Rs. 65,731.72 Lakhs in the corresponding period of the previous year. Net profit after tax was Rs. 135.45 Lakhs compared to Rs. 921.16 Lakhs in 9M FY25.

Standalone Financial Results

Quarterly Standalone Performance

Standalone revenue for Q3FY26 reached Rs. 6,279.23 Lakhs, significantly higher than Rs. 3,514.18 Lakhs in Q3FY25. The company reported standalone profit after tax of Rs. 132.93 Lakhs compared to Rs. 825.93 Lakhs in the previous year quarter.

Nine-Month Standalone Results

Standalone revenue for nine months increased to Rs. 14,162.45 Lakhs from Rs. 10,605.00 Lakhs in 9M FY25. However, the company reported a loss of Rs. (518.09) Lakhs compared to a profit of Rs. 68.27 Lakhs in the previous year.

Key Business Developments

The published results highlight several major contracts including the Andhra Pradesh State Fibernet Limited project worth Rs. 160 Crores and the new BharatNet Project Phase III with an expected order value of Rs. 119.74 Crores. The company continues to manage various legal proceedings while maintaining its focus on technology services across multiple geographies.

Trigyn Technologies Limited (TTL) has received a significant boost to its employee stock option plan, as the company announced in-principle approval from both the National Stock Exchange (NSE) and Bombay Stock Exchange (BSE) for listing up to 4,50,000 equity shares under its Employee Stock Option Plan 2025.

Exchange Approval Details

The approval letters, issued on August 12, 2025, bear the reference numbers NSE/LIST/49438 and DCS/AMAL/RG/IP/3741/2025-26 for NSE and BSE respectively. This move allows TTL to allot equity shares to employees upon the exercise of their stock options, subject to various listing conditions.

Conditions for Approval

The exchanges have stipulated several conditions for the approval, including:

1. Compliance with SEBI regulations
2. Receipt of necessary statutory approvals
3. Submission of required documentation

It's important to note that the exchanges reserve the right to withdraw approval if the submitted information is found to be incomplete or misleading.

Financial Performance

While the ESOP approval marks a positive development for Trigyn Technologies, the company's recent financial results present a mixed picture:

Consolidated Results

The company reported a consolidated revenue from operations of ₹22,450.00 lakhs, down from ₹24,194.44 lakhs in the same quarter of the previous year. More notably, Trigyn Technologies recorded a net loss of ₹460.86 lakhs, compared to a net profit of ₹761.38 lakhs in the corresponding quarter.

Standalone Results

On a standalone basis, the company's performance also showed a decline. Revenue from operations decreased to ₹3,541.02 lakhs from ₹3,667.47 lakhs in the corresponding quarter of the previous year. The net loss widened to ₹499.02 lakhs from ₹371.45 lakhs.

Other Developments

In addition to the ESOP approval and financial results, Trigyn Technologies announced several other key developments:

1. The Board of Directors approved the roles and responsibilities for Mrs. Bhavana Rao Potluri as Executive Vice Chair, effective immediately.

2. The company received approval to incorporate a Wholly Owned Subsidiary in Dubai, United Arab Emirates, through its existing wholly owned subsidiary, TTI.

3. Trigyn Technologies is currently engaged in arbitration proceedings with Nashik Municipal Smart City Development Corporation Ltd (NMSCDCL) following a termination notice issued on September 4, 2023.

4. The company is facing a show cause cum demand notice from the GST department for ₹9.08 crores, disallowing Input Tax Credit claimed during FY 2019-20 to FY 2022-23.

As Trigyn Technologies navigates these challenges and opportunities, the approval of the ESOP 2025 could serve as a tool to attract and retain talent, which may be crucial for the company's future performance and growth strategies.